Technical Analysis for TROV - TrovaGene, Inc.

Grade Last Price % Change Price Change
grade F 0.585 11.43% 0.06
TROV closed up 11.43 percent on Friday, January 18, 2019, on 2.9 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical TROV trend table...

Date Alert Name Type % Chg
Jan 18 Crossed Above 20 DMA Bullish 0.00%
Jan 18 Pocket Pivot Bullish Swing Setup 0.00%
Jan 18 Above Upper BB Strength 0.00%
Jan 18 Upper Bollinger Band Touch Strength 0.00%
Jan 17 Hammer Candlestick Bullish 11.43%
Jan 17 New 52 Week Low Weakness 11.43%
Jan 17 Lower Bollinger Band Touch Weakness 11.43%
Jan 16 Narrow Range Bar Range Contraction 11.43%
Jan 16 Doji - Bullish? Reversal 11.43%
Jan 14 20 DMA Resistance Bearish 11.32%

Older signals for TROV ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Trovagene Inc., a development stage molecular diagnostic company, focuses on the development and commercialization of proprietary diagnostic technologies for use in patient/disease screening and monitoring in various medical disciplines. The company's urine-based testing platform facilitates to enhance the management of cancer care and women's healthcare. Its proprietary urine-based molecular diagnostic tests are used to detect transrenal DNA and RNA that are cell-free nucleic acids found in urine. The company's technology is applied in various testing, such as tumor detection and monitoring, prenatal genetic testing, infectious diseases, tissue transplantation, and forensic identification, as well as for patient selection in clinical trials. In addition, it owns rights to nucleophosmin-1, an informative biomarker for acute myeloid leukemia and mutations in the SF3B1 gene that are to be associated with chemotherapy response in chronic lymphocytic leukemia patients. The company was formerly known as Xenomics, Inc. and changed its name to Trovagene Inc. in January 2010. Trovagene Inc. was founded in 1999 and is headquartered in San Diego, California.
Is TROV a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 5.64
52 Week Low 0.47
Average Volume 284,658
200-Day Moving Average 1.3543
50-Day Moving Average 0.6427
20-Day Moving Average 0.5432
10-Day Moving Average 0.5451
Average True Range 0.0575
ADX 22.55
+DI 18.542
-DI 21.7586
Chandelier Exit (Long, 3 ATRs ) 0.4875
Chandelier Exit (Short, 3 ATRs ) 0.6425
Upper Bollinger Band 0.5812
Lower Bollinger Band 0.5052
Percent B (%b) 1.05
BandWidth 13.991164
MACD Line -0.027
MACD Signal Line -0.0356
MACD Histogram 0.0086
Fundamentals Value
Market Cap 21.8 Million
Num Shares 37.3 Million
EPS -1.25
Price-to-Earnings (P/E) Ratio -0.47
Price-to-Sales 76.85
Price-to-Book 6.46
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.72
Resistance 3 (R3) 0.71 0.65 0.70
Resistance 2 (R2) 0.65 0.62 0.66 0.69
Resistance 1 (R1) 0.62 0.60 0.64 0.63 0.68
Pivot Point 0.57 0.57 0.57 0.57 0.57
Support 1 (S1) 0.53 0.53 0.55 0.54 0.49
Support 2 (S2) 0.48 0.51 0.48 0.48
Support 3 (S3) 0.44 0.48 0.48
Support 4 (S4) 0.45